We have detected and cloned two rearrangements in the T-cell receptor a locus from a clone of somatic cell hybrids carrying a t(14;14)(qll;q32) chromosomal translocation derived from an ataxia telangiectasia patient with T-cell chronic lymphocytic leukemia. The T-cell clone carrying the t(14;14) chromosomal translocation was known to be present for >10 years before the onset of overt leukemia. One molecular rearrangement of the T-cell receptor a locus corresponded to a functional variable-joining region (V-J) joining, whereas the other derived from the breakpoint of the t(14;14)(qll;q32) translocation. Chromosomal in situ hybridization of the probe derived from the t(14;14) breakpoint localized the breakpoint region to 14q32.1, apparently the same region that is involved in another ataxia telangiectasia characteristic chromosome translocation, t(7;14)(q35;q32). The 14q32.1 breakpoint is at least 10,000 kilobase pairs (kbp) centromeric to the immunoglobulin heavy chain locus. Sequence analysis of the breakpoint indicates the involvement of a Ja sequence during the translocation. Comigration of high-molecular weight DNA fragments involved with t(7;14) and t(14;14) translocations suggests the presence of a cluster of breakpoints in the 14q32.1 region, the site of a putative oncogene, TCLI.
Many malignancies of the hematopoietic lineage exhibit nonrandom chromosomal translocations (1) (2) (3) . B-cell tumors are frequently associated with the t(8;14)(q24;q32) translocation in Burkitt lymphomas, with the t(14;18)(q21;q32) translocation in follicular lymphoma, and with the t(11;14)-(ql3;q32) translocation in B-cell chronic lymphocytic leukemia and sporadically in multiple myeloma and some nonHodgkin lymphomas (4, 5) . Although lymphocytic neoplasms of T-cell origin are considerably less common than their B-cell counterparts, chromosomal translocations and inversions are also present in many of these cases. In both B-and T-cell tumors, immunoglobulin and T-cell receptor (TCR) genes, respectively, are involved in these translocations, and oncogenes or putative oncogene loci are nonrandomly altered and/or activated during the translocation event (5) . Loci that together with the TCR genes are frequently involved in T-cell leukemias map at bands 14q32.1, llpl3, and 10q24 (3, (6) (7) (8) (9) .
In ataxia telangiectasia (AT), a syndrome characterized by cerebellar ataxia, variable levels ofT-cell immunodeficiency, and hypersensitivity to ionizing radiation, both nonrandom chromosomal translocations and lymphoid neoplasia are frequent events (10) . Furthermore, preleukemic clonal expansions of cells carrying specific chromosomal abnormalities, such as the inv(14)(qll;q32) inversion or the t(14;14)-(qll;q32) translocation, are often observed in these patients (2, 11) .
The AT case herein characterized at the molecular level has been widely studied in the past 20 years (1, 2, 12, 13) . The patient, a 48-year-old woman with AT, developed a leukemic clone carrying a t(14;14)(qll;q32) chromosomal translocation and multiple additional abnormalities in 1977. Ten years previously, a clinically nonneoplastic clone with only the t(14;14) rearrangement had been demonstrated in her circulating T cells (2) . To identify loci involved in the leukemogenic process, we undertook molecular analysis of this chromosome translocation in the leukemic T cells of this patient.
MATERIALS AND METHODS Somatic Cell Hybrids. Mouse BW5147 T-cell lymphoma cells were fused with the patient's T lymphocytes as described (14) . A hybrid, 513AC3B10 (Fig. 1 ) was isolated that carried the 14q+(14pter-+14q32::14qll-*14q32) derived from the t(14;14)(qll;q32) translocation observed in preleukemic and leukemic cells of the patient.
Hybrid 5263C17 is a rodent-human hybrid that carries a t(X;14)(ql3;q32) chromosome translocation (15) . Hybrid M44C12S9 is a hybrid between mouse myeloma (NP3) and an endemic Burkitt lymphoma (P3HR-1) containing only the 14q+ chromosome derived from the t(8;14)(q24;q32) (16) . Hybrid 588-AA3 contains the 8q+ chromosome (8pter-* 8q24::14qll-44qter) resulting from the translocation that joins a region containing all of chromosome 14 telomeric to a region -36 kilobases (kb) 5' to the constant (C) region ofthe TCR chain locus (14qll-+l4qter) to a region 3' of c-myc on chromosome 8 (17) . No normal chromosome 14 is observed in the parental cell line or in hybrid 588-AA3 (18) . These hybrids were used for regional chromosomal localization. Other hybrid cell lines used are briefly described in the text and in figure legends.
Southern Transfer Hybridizations, Molecular Cloning, and
Sequencing. The probes pMI12B2.3 and pM11l detect the TCR Ja segment at 62 and 58 kilobase pairs (kbp) from the C region, respectively (M.I. and C.M.C., unpublished results). Southern transfer hybridization procedures, genomic cloning in the A phage vector EMBL3, and nucleotide sequence analysis using the Sanger dideoxynucleotide chain-termination method on M13-cloned single-strand DNA have been described (19) . Sequences were analyzed using the University of Wisconsin Computer Group Software (20 In Situ Hybridization. Chromosomal in situ hybridization was performed as described (21) . The probe was pB0.9, a genomic clone containing a 0.9-kb insert, labeled with
[3H]dTTP (NEN) by nick translation.
Transverse Alternating Field Electrophoresis. High-molecular weight DNA from various cell lines was prepared, digested, and electrophoresed using a transverse alternating field apparatus as described (22) . The pulses used were 4 sec for the first 30 min and 45 sec for the following 16 hr. After electrophoresis the gel was stained in ethidium bromide (2 ,4g/ml) for 30 min, destained in H20 for 30 min, photographed, depurinated for 15 min in 0.1 M HCI, and transferred to nitrocellulose (0.2 ,um) (Schleicher & Schuell) or Zetaprobe membranes (Bio-Rad), then baked for 2 hr at 80°C, and hybridized using described procedures (19) .
RESULTS
Molecular Cloning of the Two Rearranged Ja Alleles.
Rearrangements of the TCR a/8 locus were examined using several genomic probes derived from a region encompassing 120 kbp of the locus for TCR-a and TCR-8 (23) in DNA from the somatic cell hybrid, 513AC3B10, carrying the 14q+ chromosome (14pter-14q32::14qll-d4qter) from the AT patient. No signal was detected using a probe that encompasses the J5 region, pMI19 (23) (data not shown), indicating deletion of both J6 alleles on the 14q+ chromosome. Use of pMI11, which is -58 kbp 5' to Ca (Fig. 2 ) and 3' to CB, revealed a 9-kbp BamHI restriction fragment in addition to the 13-kbp germ-line BamHI fragment (Fig. 3A) . A second rearranged fragment (Fig. 3B ), but no germ-line band, was detected using pMI12B3.2 (see Fig. 2 ), which is 5 kbp 5' to pMI11. To determine whether these non-germ-line fragments represented functional rearrangements ofthe TCR and/or the junction point between 14q11 and 14q32, a genomic library constructed from the hybrid 513AC3B10 was screened with nick-translated probes pMI11 and pMI12B3.2. Of -500,000 plaques, 6 positive clones were identified in the second screening and hybridized individually to each probe. Because the two rearrangements were not >5 kb apart (see Fig. 2 ) and no other human chromosome 14 sequences were present in the hybrid library, two classes of clones were delineated: (i) three clones positive for hybridization with both pMI11 and pMI12B3.5, and (ii) three clones positive with pMI11 only. Restriction analysis of two representative clones, B and H (see Fig. 2 ), confirmed that we had cloned both rearrangements.
Regional Chromosomal Origin of the Two Classes of Rearranged Clones. To determine which of the two clones represented the junction of the chromosomal translocation, somatic cell hybrid 588-AA3 DNA, which contains an 8q+ chromosome (8pter--8q24::14q11-d4qter) derived from the human leukemic SKW3 cell line, the breakpoint of which has been well characterized (17) , was used to map the 5' end of the clones to a region either proximal or distal to the Ja locus. This hybrid contains sequences telomeric to the Ja R region, which is situated 30 kbp 5' to the Ca region (23) . The probe pSE3.5 derived from clone H, 5' to the breakpoint (see Fig.  2 ), did not hybridize with 588-AA3 DNA but did segregate concordantly with chromosome 14 in other hybrid DNA (data not shown). Thus, the clone H sequences presumably derive from a region centromeric to the Ca locus. By contrast, a probe 5' to the breakpoint of clone B, pBO.9 (see Fig. 2 ), did hybridize with the DNA from the 588-AA3 hybrid and with DNA of other hybrids carrying chromosome 14 (see Fig. 4) ; thus probe pBO.9 is telomeric to the Ja R region. Probe pB0.9 sequences are present in DNA from the 5263C17 hybrid, which retains a 14q+(14pter-14q32::Xql3-*Xqter) in which the chromosome 14 translocation point is pr D14S1 locus (13) . Thus, the locus detected by ; centromeric to the polymorphic D14S1 locus, X 14q32.2 (24) , and to the immunoglobulin heavj which maps to 14q32.3, and telomeric to the J These data suggested that pBO.9 represents s rived from a region between 14q11 (telomeric to and 14q32.2.
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. AT patient and the isolation of a subclone, pE/S, from the t(7;14) that also maps to 14q32.1 (3). Chromosomal walking techniques using the two probes pE/S and pBO.9 and genomic Southern blots indicated that these two probes were at least 50 kbp apart. Pulsed field electrophoresis of highmolecular weight DNA fragments followed by Southern transfer and hybridization to the two probes indicated that the two probes may be contained within a 250-kbp Sf1 I restriction fragment and a 1050-kbp Mlu I restriction fragment; no comigration of the two loci was seen after Sal I or Nru I digestion (Fig. 6) . Thus, the two probes may be within the same 250-kbp Sf1 I restriction fragment. Molecular sizes in kb are indicated on the side. Probes pBO.9 and pE/S were used on the same filters.
patient who later developed T-cell chronic lymphocytic leukemia. These two rearrangements represent a functional V-J joining at 58 kbp 5' to Ca and the translocation breakpoint at 65 kb 5' to Ca, respectively. Functional V-J joining on the nontranslocated allele was also reported in the case of a chromosomal inversion [inv(14)(qll;q32)] in another patient with AT and T-cell leukemia (8) . Thus, with both patients, the capacity to properly assemble antigen receptor genes remained intact. It is, however, possible that the presence of a functional allele in the clonal malignant population is required for the cell to pursue a differentiation program in light of the fact that B and T malignant cells carrying a chromosomal translocation also usually produce immunoglobulins or T-cell receptors.
The t(14;14) chromosomal breakpoint characterized here was the result of a recombination event between a region identified as a putative Ja on 14q11 and a previously undescribed locus on 14q32.1. This chromosome translocation, similar to the others involving chromosome 14q11 in T-cell neoplasms (17) , occurred in proximity of a heptamer on 14q11, in front of a pseudo Ja segment, suggesting that breakage occurred during an attempt at V-J joining by the lymphocytes of the AT patient. Chromosomal translocations and other aberrant recombination events in AT patients frequently involve the 14q11 region, a highly active region during T-cell differentiation, as V-J joining proceeds due to the presence of two T-cell receptor loci, a/8, on 14q11, and to the large number of Ja segments (>40) and two J8 segments spanning over 100 kb. The sheer size ofthis 100-kbp region might contribute to errors during T-cell receptor gene rearrangement, leading to translocations. The locus at 14q32.1 designated TCLI is frequently involved in chromosome translocations in AT-associated leukemias (3, 7) and non-AT leukemias (6) . The TCLI locus is -10,000 kbp centromeric to and distinct from the 14q32.3 subband where the immunoglobulin heavy chain locus maps. To date, four other chromosomal breakpoints have been localized to the 14q32.1 subband by molecular cloning (3, 6, 7) and another two through cytogenic analysis (26) . Breakpoints observed in this region are not clearly clustered, a situation that resembles that seen in endemic Burkitt lymphomas with the t(8;14) translocation and in chronic myelogenous leukemia with the t(9;22) translocation. Our transverse alternating field electrophoresis data suggest comigration of probes pE/S and pBO.9, on a large Sfl I fragment, indicating that these two breakpoints may begin to define a breakpoint cluster if they can be linked by chromosome walking.
The patient presented in this study reportedly carried a clonal expansion of T cells with the t(14;14)(qll;q32) translocation 10 yr before overt leukemia. The same clone appeared to retain the capacity to differentiate along distinct maturation pathways of T helper and suppressor cells (12) . In this light, the occurrence of lymphoid malignancy in AT patients does not seem unexpected. From previous reports (1, 2, 11, 26, 27) , and the data presented here, the sequence of events illustrated in Fig. 7 in the development of T-cell leukemia associated with AT seems possible. Chromosomal translocations are nonrandom events in these patients and normally involve 14q11 (TCRa/8), 7q35 (TCRP), 7p14 (TCRy), and 14q32.1 (TCL1). Although reciprocal translocations involving 14q11, 7q35, and 7pl4 are not known to result in malignant transformation, the translocations involving 14q32.1 are associated with a proliferative advantage (Fig. 7 Interestingly, other alterations, such as the inversion with duplication of a region 25 kb 5' to Clu of the immunoglobulin heavy chain locus, were previously reported in the patient studied here (13) . We detected a similar inversion with duplication on the 14q+ of another T-cell leukemia in an AT patient which had a t(7;14)(q35;q32) translocation (3) . Whether this alteration has any significance for the leukemogenic process remains unclear, but this alteration does appear to occur nonrandomly in the cells of AT patients.
